• About
• Links
• Contact
• Sitemap
• 

The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

Summary

The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global cardiovascular diseases therapeutics market. The report analyzes the markets for cardiovascular disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis.

Scope

The scope of this report includes:

Annualized market data for the cardiovascular diseases therapeutics market from 2000 to 2008, forecast forward to 2015

Analysis of the leading therapeutic segments including hypertension, dyslipidemia and thrombosis

Analysis of the cardiovascular diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan

Market characterization of the cardiovascular diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns

Key drivers and barriers that have a significant impact on the market

Coverage of pipeline molecules in various phases of drug development

Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, Sanofi-aventis, Pfizer Inc and Merck & Co

Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global cardiovascular diseases therapeutics market

Reasons to buy

The report will aid Business Development and marketing executives strategizing their product launches. It will allow you to;

Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the cardiovascular diseases therapeutics market.

Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the cardiovascular diseases therapeutics market in future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

What’s the next big thing in the global cardiovascular diseases therapeutics landscape? – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 4

• 1.1 List of Tables 7
• 1.2 List of Figures 11

2 Global Cardiovascular Therapeutics Market: Scope of Research 13

• 2.1 Introduction 13
• 2.2 Report Guidance 13

3 Global Cardiovascular Therapeutics Market: Market Characterization 14

• 3.1 Market Forecasts 14
• 3.2 Branded Vs Generics 15
• 3.3 Average Cost of Therapy 16
• 3.4 Volume 17
• 3.5 Usage Patterns 18
  • 3.5.1 Diseased Population 18
  • 3.5.2 Treatment Seeking Population 19
  • 3.5.3 Diagnosis Population 21
  • 3.5.4 Prescription Population 22
  • 3.5.5 Usage Patterns 23
  • 3.5.6 Geographical Distribution 24

4 Global Cardiovascular Therapeutics Market: US Market 25

• 4.1 Market Overview 25
• 4.2 Market Forecasts 25
• 4.3 Average Cost of Therapy 26
• 4.4 Volume 27
• 4.5 Usage Patterns 28
  • 4.5.1 Diseased Population 28
  • 4.5.2 Treatment Seeking Population 29
  • 4.5.3 Diagnosis Population 30
  • 4.5.4 Prescription Population 31
  • 4.5.5 Usage Patterns 32

5 Global Cardiovascular Therapeutics Market: European Market 34

• 5.1 Market Overview 34
• 5.2 Market Forecasts 34
• 5.3 Average Cost of Therapy 35
• 5.4 Volume 36
• 5.5 Usage Patterns 37
  • 5.5.1 Diseased Population 37
  • 5.5.2 Treatment Seeking Population 38
  • 5.5.3 Diagnosis Population 39
  • 5.5.4 Prescription Population 40
  • 5.5.5 Usage Patterns 41

6 Global Cardiovascular Therapeutics Market : Japan Market 43

• 6.1 Market Forecasts 43
• 6.2 Average Cost of Therapy 44
• 6.3 Volume 45
• 6.4 Usage Patterns 46
  • 6.4.1 Diseased Population 46
  • 6.4.2 Treatment Seeking Population 47
  • 6.4.3 Prescription Population 49
  • 6.4.4 Usage Patterns 49

7 Global Hypertension Therapeutics Market 51

• 7.1 Market Forecasts 51
• 7.2 Average Cost of Therapy 52
• 7.3 Volume 53
• 7.4 Usage Patterns 54
  • 7.4.1 Diseased Population 54
  • 7.4.2 Treatment Seeking Population 55
  • 7.4.3 Diagnosis Population 56
  • 7.4.4 Prescription Population 57
  • 7.4.5 Usage Patterns 58

8 Global Dyslipidemia Therapeutics Market 60

• 8.1 Market Forecasts 60
• 8.2 Average Cost of Therapy 61
• 8.3 Volume 62
• 8.4 Usage Patterns 63
  • 8.4.1 Diseased Population 63
  • 8.4.2 Treatment Seeking Population 64
  • 8.4.3 Diagnosis Population 65
  • 8.4.4 Prescription Population 66
  • 8.4.5 Usage Patterns 67

9 Global Thrombosis Therapeutics Market 69

• 9.1 Market Forecasts 69
• 9.2 Volume 70
• 9.3 Average Cost of Therapy 71
• 9.4 Usage Patterns 72
  • 9.4.1 Diseased Population 72
  • 9.4.2 Treatment Seeking Population 73
  • 9.4.3 Diagnosis Population 74
  • 9.4.4 Prescription Population 75
  • 9.4.5 Usage Patterns 76

10 Global Cardiovascular Therapeutics Market: Market Drivers and Restraints 78

• 10.1 Market Drivers 78
  • 10.1.1 Steady Increase in the Elderly Population 78
  • 10.1.2 Stable Increase in Incidence Rates for Cardiovascular Diseases 79
  • 10.1.3 Increase in Awareness Levels of Disease Progression and Etiology 79
• 10.2 Market Restraints 79
  • 10.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers 79
  • 10.2.2 Reimbursement Restrictions on Drug Classes for Certain Cardiovascular Disease Drug Classes Restricts the Market Growth 80

11 Global Cardiovascular Therapeutics Market : Unmet Needs 81

12 Global Cardiovascular Therapeutics Market : Key Market Trends 82

• 12.1 Increase in Disease Incidence and Prevalence Rates 82
• 12.2 Product Pipeline 82
• 12.3 Advertising and Commercialization 83
• 12.4 Regulatory trends – Current Reimbursement Scenario 83
  • 12.4.1 The Budget Impact on Drug Reimbursements 83
  • 12.4.2 Reliability of Generic Formulations as a Cost Cutting Measure 83

13 Global Cardiovascular Therapeutics Market: Competitive Landscape 84

• 13.1 Overview 84
• 13.2 Market Share Analysis 84
• 13.3 Competitive Profiling 85
  • 13.3.1 Pfizer 86
  • 13.3.2 Sanofi-Aventis 86
  • 13.3.3 Merck 87
  • 13.3.4 Novartis 87

14 Global Cardiovascular Therapeutics Market: M&A Landscape 88

• 14.1 Mergers and Acquisitions 88
  • 14.1.1 Overview 88
• 14.2 Licensing Agreements 90
  • 14.2.1 Research Phase 93
  • 14.2.2 Preclinical 93
  • 14.2.3 Phase I 94
  • 14.2.4 Phase PI/II 94
  • 14.2.5 Phase II 95
  • 14.2.6 Phase III 96
  • 14.2.7 Filed 96

15 Global Cardiovascular Therapeutics Market : Appendix 98

• 15.1 Market Definitions 98
• 15.2 Abbreviations 98
• 15.3 Research Methodology 98
  • 15.3.1 Coverage 99
  • 15.3.2 Secondary Research 99
  • 15.3.3 Forecasts 100
  • 15.3.4 Primary Research 102
  • 15.3.5 Expert Panels 102
• 15.4 Contact Us 102
• 15.5 Disclaimer 102

1.1 List of Tables

• Table 1: Global Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008 14
• Table 2: Global Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 14
• Table 3: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2000-2008 15
• Table 4: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2008-2015 16
• Table 5: Global Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 16
• Table 6: Global Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2008-2015 17
• Table 7: Global Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008 17
• Table 8: Global Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 18
• Table 9: Global Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 19
• Table 10: Global Cardiovascular Therapeutics Market, Forecasts for Diseased Population , 2008-2015 19
• Table 11: Global Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 20
• Table 12: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 20
• Table 13: Global Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 21
• Table 14: Global Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 21
• Table 15: Global Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 22
• Table 16: Global Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 22
• Table 17: Global Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 23
• Table 18: Global Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 24
• Table 19: US Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008 26
• Table 20: US Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 26
• Table 21: US Cardiovascular Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 27
• Table 22: US Cardiovascular Therapeutics Market, Forecasts for the Average Cost of Therapy ($), 2008-2015 27
• Table 23: US Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008 27
• Table 24: US Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 28
• Table 25: US Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 28
• Table 26: US Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015 29
• Table 27: US Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 30
• Table 28: US Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 30
• Table 29: US Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population(000’), 2000-2008 31
• Table 30: US Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population(000’), 2008-2015 31
• Table 31: US Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 32
• Table 32: US Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 32
• Table 33: US Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 33
• Table 34: US Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 33
• Table 35: European Cardiovascular Therapeutics Market, Historical Revenues ($bn), 2000-2008 34
• Table 36: European Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 35
• Table 37: European Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Treatment, 2000-2008 35
• Table 38: European Cardiovascular Therapeutics Market, Forecasts for Average Cost of Treatment, 2008-2015 36
• Table 39: European Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008 36
• Table 40: European Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 37
• Table 41: European Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 37
• Table 42: European Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015 38
• Table 43: European Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 38
• Table 44: European Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 39
• Table 45: European Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 39
• Table 46: European Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 40
• Table 47: European Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 40
• Table 48: European Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 41
• Table 49: European Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 42
• Table 50: European Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 42
• Table 51: Japan Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008 43
• Table 52: Japan Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 43
• Table 53: Japan Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 44
• Table 54: Japan Cardiovascular Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 44
• Table 55: Japan Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008 45
• Table 56: Japan Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 45
• Table 57: Japan Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 46
• Table 58: Japan Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015 46
• Table 59: Japan Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 47
• Table 60: Japan Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 47
• Table 61: Japan Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 48
• Table 62: Japan Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 48
• Table 63: Japan Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 49
• Table 64: Japan Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 49
• Table 65: Japan Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 50
• Table 66: Japan Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 50
• Table 67: Global Hypertension Therapeutics Market, Historical Revenues ($m), 2000-2008 51
• Table 68: Global Hypertension Therapeutics Market, Revenue Forecasts ($m), 2008-2015 51
• Table 69: Global Hypertension Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 52
• Table 70: Global Hypertension Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 52
• Table 71: Global Hypertension Therapeutics Market, Historical Figures for Volume, 2000-2008 53
• Table 72: Global Hypertension Therapeutics Market, Forecasts for Volume, 2008-2015 53
• Table 73: Global Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 54
• Table 74: Global Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015 54
• Table 75: Global Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 55
• Table 76: Global Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 55
• Table 77: Global Hypertension Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 56
• Table 78: Global Hypertension Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 56
• Table 79: Global Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 57
• Table 80: Global Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015 57
• Table 81: Global Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 58
• Table 82: Global Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 59
• Table 83: Global Dyslipidemia Therapeutics Market, Historical Revenues ($m), 2000-2008 60
• Table 84: Global Dyslipidemia Therapeutics Market, Revenue Forecasts ($m), 2008-2015 60
• Table 85: Global Dyslipidemia Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 61
• Table 86: Global Dyslipidemia Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 61
• Table 87: Global Dyslipidemia Therapeutics Market, Historical Figures for Volume, 2000-2008 62
• Table 88: Global Dyslipidemia Therapeutics Market, Forecasts for Volume, 2008-2015 62
• Table 89: Global Dyslipidemia Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 63
• Table 90: Global Dyslipidemia Therapeutics Market, Forecasts for Diseased Population, 2008-2015 63
• Table 91: Global Dyslipidemia Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 64
• Table 92: Global Dyslipidemia Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 64
• Table 93: Global Dyslipidemia Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 65
• Table 94: Global Dyslipidemia Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 65
• Table 95: Global Dyslipidemia Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 66
• Table 96: Global Dyslipidemia Therapeutics Market, Forecasts for Prescription Population, 2008-2015 66
• Table 97: Global Dyslipidemia Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 67
• Table 98: Global Dyslipidemia Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 68
• Table 99: Global Thrombosis Therapeutics Market, Historical Revenues ($m), 2000-2008 69
• Table 100: Global Thrombosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015 69
• Table 101: Global Thrombosis Therapeutics Market, Historical Figures for Volume, 2000-2008 70
• Table 102: Global Thrombosis Therapeutics Market, Forecasts for Volume, 2008-2015 70
• Table 103: Global Thrombosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 71
• Table 104: Global Thrombosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 71
• Table 105: Global Thrombosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 72
• Table 106: Global Thrombosis Therapeutics Market, Forecast Figures for Diseased Population, 2008-2015 72
• Table 107: Global Thrombosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 73
• Table 108: Global Thrombosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 73
• Table 109: Global Thrombosis Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 74
• Table 110: Global Thrombosis Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 74
• Table 111: Global Thrombosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 75
• Table 112: Global Thrombosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015 75
• Table 113: Global Thrombosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 76
• Table 114: Global Thrombosis Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 77
• Table 115: Global Cardiovascular Therapeutics Market, Market Drivers, 2008 78
• Table 116: Global Cardiovascular Therapeutics Market, Market Restraints, 2008 79
• Table 117: Global Cardiovascular Therapeutics Market, Major Drug Patent Expirations, 2008-2015 80
• Table 118:Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Research Stage, 2008-2009 93
• Table 119: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Pre-clinical Stage, 2008-2009 93
• Table 120: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PI Stage, 2008-2009 94
• Table 121: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PI/PII Stage, 2008-2009 94
• Table 122: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PII Stage, 2008-2009 95
• Table 123: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PIII stage, 2008-2009 96
• Table 124: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Filed Stage, 2008-2009 96

1.2 List of Figures

• Figure 1: Global Cardiovascular Therapeutics Market, Revenue Forecast, 2000-2015 14
• Figure 2: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2000-2015 15
• Figure 3: Global Cardiovascular Therapeutics Market, Average Cost of Therapy ($), | 2000-2015 16
• Figure 4: Global Cardiovascular Therapeutics Market, Volume, 2000-2015 17
• Figure 5: Global Cardiovascular Therapeutics Market, Global Diseased Population, 2000-2015 18
• Figure 6: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 20
• Figure 7: Global Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 21
• Figure 8: Global Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 22
• Figure 9: Cardiovascular Therapeutics Market, Global, Forecasts for Treatment Patterns, 2000-2015 23
• Figure 10: Global Cardiovascular Therapeutics Market, Geographical Distribution of Revenues ($bn), 2000-2015 24
• Figure 11: US Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 25
• Figure 12: US Cardiovascular Therapeutics Market, Average Cost of Therapy ($), 2000-2015 26
• Figure 13: US Cardiovascular Therapeutics Market, Volume (million), 2000-2015 27
• Figure 14: US Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015 28
• Figure 15: US Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 29
• Figure 16: US Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 30
• Figure 17: US Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 31
• Figure 18: US Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 32
• Figure 19: European Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 34
• Figure 20: European Cardiovascular Therapeutics Market, Forecasts for Average Cost of Treatment ($), 2000-2015 35
• Figure 21: European Cardiovascular Therapeutics Market, Forecasts for Volume, 2000-2015 36
• Figure 22: European Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015 37
• Figure 23: European Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 38
• Figure 24: European Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 39
• Figure 25: European Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 40
• Figure 26: European Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 41
• Figure 27: Japan Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 43
• Figure 28: Japan Cardiovascular Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 44
• Figure 29: Japan Cardiovascular Therapeutics Market, Forecasts for Volume, 2000-2015 45
• Figure 30: Japan Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015 46
• Figure 31: Japan Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 47
• Figure 32: Japan Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 48
• Figure 33: Japan Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 49
• Figure 34: Japan Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 50
• Figure 35: Global Hypertension Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 51
• Figure 36: Global Hypertension Therapeutics Market, Average Cost of Therapy ($), 2000-2015 52
• Figure 37: Global Hypertension Therapeutics Market, Volume, 2000-2015 53
• Figure 38: Global Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015 54
• Figure 39: Global Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 55
• Figure 40: Global Hypertension Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 56
• Figure 41: Global Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015 57
• Figure 42: Global Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 58
• Figure 43: Global Dyslipidemia Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 60
• Figure 44: Global Dyslipidemia Therapeutics Market, Average Cost of Therapy ($), 2000-2015 61
• Figure 45: Global Dyslipidemia Therapeutics Market, Volume, 2000-2015 62
• Figure 46: Global Dyslipidemia Therapeutics Market, Forecasts for Diseased Population, 2000-2015 63
• Figure 47: Global Dyslipidemia Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 64
• Figure 48: Global Dyslipidemia Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 65
• Figure 49: Global Dyslipidemia Therapeutics Market, Forecasts for Prescription Population, 2000-2015 66
• Figure 50: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Patterns, 2000-2015 67
• Figure 51: Global Thrombosis Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 69
• Figure 52: Global Thrombosis Therapeutics Market, Volume, 2000-2015 70
• Figure 53: Global Thrombosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 71
• Figure 54: Global Thrombosis Therapeutics Market, Forecasts for Diseased Population, 2000-2015 72
• Figure 55: Global Thrombosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 73
• Figure 56: Global Thrombosis Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 74
• Figure 57: Global Thrombosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015 75
• Figure 58: Global Thrombosis Therapeutics Market, Forecasts for Treatment Patterns, 2000-2015 76
• Figure 59: Global Cardiovascular Disease Therapeutics Market, Market Indicators, 2008 78
• Figure 60: Global Cardiovascular Therapeutics Market, Analysis of Unmet Needs for Major Disease Sectors, 2008 81
• Figure 61: Global Cardiovascular Disease Therapeutics Market, Key Market Events, 2008-2015 82
• Figure 62: Global Cardiovascular Therapeutics Market, Market Share of Top Manufacturers, 2008 84
• Figure 63: Global Cardiovascular Therapeutics Market, Benchmarking Analysis for Top Four Manufacturers, 2008 85
• Figure 64: Global Cardiovascular Therapeutics Market, Benchmarking Analysis for Top Four Manufacturers Pipeline and Unmet Need Analysis, 2008 85
• Figure 65: Global Cardiovascular Therapeutics Market, M&A Deals by Geography, 2008 88
• Figure 66: Global Cardiovascular Therapeutics Market, M&A Deals by Deal Size, 2008 88
• Figure 67: Global Cardiovascular Therapeutics Market, M&A Deals by Phase, 2008 89
• Figure 68: Global Cardiovascular Therapeutics Market, Top Three M&A Deals, 2008 89
• Figure 69: Global Cardiovascular Therapeutics Market, Licensing Agreement by Geography, 2008 91
• Figure 70: Global Cardiovascular Therapeutics Market, Licensing Agreement by Deal Size, 2008 91
• Figure 71: Global Cardiovascular Therapeutics Market, Licensing Agreements by Phase of Development, 2008 92
• Figure 72: Global Cardiovascular Therapeutics Market, Licensing Agreement by Indications, 2008 92
• Figure 73: Research Methodology 99
• Figure 74: Research Market Forecasting Methodology 101

Other users found this report page using the following search terms: hypertension dyslipidemia thrombosis market cardiovascular disease therapeutics forecast size us volume future 2009

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.